Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan- for Dapagliflozin in Management of Type 2 Diabetes Mellitus

NCT02805361 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02805361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02805361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan- for Dapagliflozin in Management of Type 2 Diabetes Mellitus
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
August 21, 2016
Completion date
July 13, 2018
Enrollment
511 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

type ii diabetes mellitus